The objective of the 18-month trial is to evaluate the natural history of geographic atrophy
by assessing the rate of progression of the geographic atrophic lesion over time.
- Clinical diagnosis of geographic atrophy secondary to age-related macular
degeneration with no CNV lesion.
- Age related